Cetus Hospital Dia Oncologia

Belo Horizonte 30110-140

0 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Leukemia

Studies at this site

• Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML — Running, not enrolling
• A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors — Completed